$IRWD Company News Ironwood Pharma loss widens as

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$IRWD Company News

Ironwood Pharma loss widens as expenses soar 8:00 a.m. April 23, 2013 - MarketWatch.com
FDA approves Ironwood's drug for IBS 10:40 a.m. Aug. 30, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 5:06 p.m. March 5, 2012 - Kate Gibson
Ironwood pins hopes on Linaclotid 10:37 a.m. Aug. 16, 2011 - MarketWatch.com
Abolish the FDA; it's insane 9:55 a.m. July 27, 2011 - James Altucher
Ironwood Pharma rallies on positive Phase 3 trial 7:39 a.m. Sept. 14, 2010 - Steve Gelsi

Nothing Should Iritate You About Synergy's Upcoming Catalysts 7:16 a.m. Nov. 6, 2013 - Seeking Alpha
Nothing Should Irritate You About Synergy's Upcoming Catalysts 7:16 a.m. Nov. 6, 2013 - Seeking Alpha
Pipeline Progress at Synergy Pharma - Analyst Blog 5:00 p.m. Nov. 4, 2013 - Zacks.com
10-Q: IRONWOOD PHARMACEUTICALS INC 4:08 p.m. Oct. 28, 2013 - Edgar Online - (EDG = 10Q, 10K)
Weekly 3-Year Low Highlight: EXC, RVBD, IRWD, SHOS 3:50 p.m. Oct. 27, 2013 - GuruFocus.com
UPDATE: Cowen & Company Upgraded Ironwood Pharmaceuticals 2:14 p.m. Oct. 24, 2013 - benzinga.com
First Week Of IRWD December 21st Options Trading 11:52 a.m. Oct. 23, 2013 - TheStreet.com
Ironwood Slips into Loss in Q3 - Analyst Blog 11:00 a.m. Oct. 23, 2013 - Zacks.com
Ironwood Pharmaceuticals Is Now Oversold (IRWD) 4:17 p.m. Oct. 22, 2013 - TheStreet.com
Ironwood Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript 12:20 p.m. Oct. 22, 2013 - Seeking Alpha
Five-Year Lows: Singapore Airlines Limited, Gold Field Ltd., Ironwood Pharmaceuticals Inc. ... 10:04 a.m. Oct. 22, 2013 - GuruFocus.com
Data on Auxilium Pharma's Xiaflex - Analyst Blog 4:35 p.m. Oct. 11, 2013 - Zacks.com
Discovery Labs Surges on Surfaxin News - Analyst Blog 4:15 p.m. Oct. 7, 2013 - Zacks.com
Forest's Patent Infringement Lawsuits - Analyst Blog 1:30 p.m. Oct. 7, 2013 - Zacks.com
Synergy Pharma's Pipeline Holds Promise - Analyst Blog 6:30 p.m. Oct. 4, 2013 - Zacks.com
Ironwood's Linzess Sales Are Ramping Up: Buy The Dip? 9:35 a.m. Sept. 19, 2013 - Seeking Alpha
Ironwood and AstraZeneca Initiate Study - Analyst Blog 4:30 p.m. Sept. 16, 2013 - Zacks.com
Positive News on Roche's Perjeta - Analyst Blog 2:30 p.m. Sept. 13, 2013 - Zacks.com
Data on Novartis' Ultibro Breezhaler - Analyst Blog 5:32 p.m. Sept. 12, 2013 - Zacks.com
Roche and Inovio Tie Up - Analyst Blog 12:00 p.m. Sept. 11, 2013 - Zacks.com


Upcoming Earnings Schedules, Conferences and Quarterly Financial Results - Research Report on Supernus, Ironwood, Neurocrine Biosciences, PhotoMedex, and Kythera 8:00 a.m. Nov. 11, 2013 - PR Newswire
Ironwood Pharmaceuticals to Present at Credit Suisse 2013 Healthcare Conference 4:00 p.m. Nov. 6, 2013 - BusinessWire
Partnership, Quarterly Reports, Acquisition, and Publication - Research Report on Alere, Ironwood, Magellan Health Services, Foundation Medicine, and InterMune 8:00 a.m. Oct. 28, 2013 - PR Newswire
Ironwood Pharmaceuticals Provides Third Quarter 2013 Investor Update 6:10 a.m. Oct. 22, 2013 - BusinessWire
Ironwood Pharmaceuticals to Host Third Quarter 2013 Investor Update Call 3:00 p.m. Oct. 8, 2013 - BusinessWire
Dividend Increases, Research Nominations, New Treatment Options, and Clinical Trials - Research Report on Covidien, Ironwood, ICON, Novadaq, and Antares 7:00 a.m. Oct. 2, 2013 - PR Newswire
Ironwood and AstraZeneca Initiate Linaclotide Phase III Trial in China for Adults with IBS-C 7:00 a.m. Sept. 10, 2013 - BusinessWire
Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference 3:00 p.m. Sept. 3, 2013 - BusinessWire
Positive Clinical Trial Results, Regulatory Wins, and New Appointments - Research Report on Incyte, Edwards, ACADIA Pharmaceuticals, Alnylam, and Ironwood 7:00 a.m. Aug. 26, 2013 - PR Newswire
Ironwood Pharmaceuticals Appoints Dr. Michael Hall as Senior Vice President of Clinical Development 7:00 a.m. Aug. 21, 2013 - BusinessWire
Earnings Releases, Investment Plans, Commencement of Clinical Trials, and FDA Applications Brighten Outlook - Research Report on Bard, Centene, Exact Sciences, Ironwood, and Merrimack 7:00 a.m. July 26, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on DHI, EZCH, IRWD and NUE 7:31 a.m. July 25, 2013 - ACCESSWIRE
Ironwood Pharmaceuticals Provides Second Quarter 2013 Investor Update 6:05 a.m. July 23, 2013 - BusinessWire
Ironwood Pharmaceuticals to Host Second Quarter 2013 Investor Update Call 3:00 p.m. July 9, 2013 - BusinessWire
Innovative Technologies that Yield Improved Treatments - Research Report on Mettler-Toledo, Ironwood, Covance, Teleflex and WuXi 7:00 a.m. June 26, 2013 - PR Newswire
Ironwood Pharmaceuticals Announces Partial Exercise of Underwriters' Option in Public Offering of Common Stock 3:00 p.m. June 4, 2013 - BusinessWire
Further Expansions and Positive Study Results Drive Healthcare Companies - Research Report on Agilent, Thermo Fisher, BG Medicine, Quest Diagnostics, and Ironwood Pharmaceuticals 7:00 a.m. May 31, 2013 - PR Newswire
Ironwood Pharmaceuticals Prices Public Offering of Common Stock 5:30 p.m. May 21, 2013 - BusinessWire
Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock 3:05 p.m. May 20, 2013 - BusinessWire
Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week(R) 2013 7:00 a.m. May 14, 2013 - BusinessWire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Perion Acquisition: Affle's Bold Leap in Ad Tech

Updated Category News Views 119

Affle's Strategic Acquisition of Perion Jumpin' through another hoop, Affle is gearing up to snag Perion in a hefty deal valued at about $420 million. For those of you not knee-deep in the ad tech sandbox, Affle—trading on the NSE as AFFLE—is aiming to ramp up its AI-driven conversion game by absorbing Perion, a veteran in the omnichannel advertising realm. "This...

Continue Reading
Ensuring Flooring Stability: Acclimation's Key Role

Updated Category News Views 191

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

Continue Reading
Navigating the Maze of Required Minimum Distributions

Updated Category News Views 145

Understanding Required Minimum Distributions Ever felt like retirement planning is walking a financial tightrope? Well, when it comes to Required Minimum Distributions (RMDs), you're tiptoeing on a wire. These IRS-mandated withdrawals aren't just accounting quirks; they’re a cornerstone of retirement income strategy—a fact unmistakably highlighted by Janie Kelly in...

Continue Reading
Nicely Network: Top Reddit Marketing for Big Brands

Updated Category News Views 166

Reddit and AI: Nicely Network's Winning Formula Straight out of New York comes the latest scoop: Nicely Network's been crowned king of the Reddit jungle, earning the title of Best Reddit Marketing Agency for Enterprise Brands this November, courtesy of Better Business Advice. Now, if you've been paying any attention to how brands are grappling with the impossible search...

Continue Reading
Context Labs Unveils AI Distillery for Enterprises

Updated Category News Views 492

Rethinking AI with Sovereignty in Mind A bouquet of tech buzzwords lands on every investor's doorstep with the unveiling of Context Labs' latest contraption. We’re talking about the AI Distillery™, which promises enterprises a way to run sovereign AI systems by keeping data in-house. Now, if you’re nodding along to the buzz, let's cut through the clutter....

Continue Reading
SICO Snags $1.6B in New Investor Mandates for 2026

Updated Category News Views 110

SICO Makes Waves with Massive New Business Wins Right out of the gate at the Gateway Gulf 2026 Forum, SICO's announcement of a whopping $1.6 billion in new business mandates had even the seasoned pros raising an eyebrow or two. There's nothing like a sweet billion-dollar figure to kickstart the day, huh? This isn't small change we're talking about; this is a tidal wave of...

Continue Reading
Tenax Therapeutics Faces Class Action Amid Massive Loss

Updated Category News Views 172

Investors Eye Deadline Amidst Legal Storm Holy moly, Tenax Therapeutics is caught with their pants down—and we're not talking loose change. Any sorry soul who bought into Tenax's promises about their TNX-103 drug is now staring down a high-stakes class action lawsuit. If you were holding on to those dreams turned nightmares between November 13, 2023, and August 7, 2026,...

Continue Reading
Decoding LRV: Smart Paint Choices for Your Home

Updated Category News Views 194

Unraveling the Secrets of LRV Nobody thought analyzing paint meant diving into light reflectance values (LRV), but that's precisely where we're headed today. Painting a room seems simple until you realize your color choice might turn your bright haven into a cave or vice versa. Thanks to some insights from Wendy Anguiano in HelloNation, let's dig into this technical...

Continue Reading
CPC's Rigorous Self-Governance Balances Power Effectively

Updated Category News Views 196

What's the Deal With Those Ancient Quotes? There's nothing like a quote from the Warring States Period to set the stage for good ol' fashioned governance chatter. Lu Buwei's words about rulers and compass points is historic, sure, but it speaks to the core need for standards in today's China. This isn't just some fortune cookie wisdom; it's a clarion call for order and...

Continue Reading
Mastering Progressive Overload: Break Workout Plateaus

Updated Category News Views 143

Getting off the Fitness Merry-Go-Round You've been hitting the gym, feeling great, and suddenly—bam! You've hit a wall so hard you might as well be a bug on a windshield. That's where our buddy Joshua Bankes comes in, explaining the magic of progressive overload for fitness buffs. Understanding Plateau Phenomena Remember, results aren't linear. As you start a new...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Innovations in Oncology at SITC Annual Meeting

Updated Category News Views 185

Replimune's Groundbreaking Presentation at SITC Replimune Group, Inc. (NASDAQ: REPL), a leading clinical stage biotechnology firm specializing in oncolytic immunotherapies, is poised to make significant waves at a prominent cancer conference. Recently, the company announced that a pivotal late-breaking abstract highlighting the IGNYTE clinical trial's primary analysis...

Continue Reading
Investors Alert: Class Action Against RCI Hospitality Holdings

Updated Category News Views 214

Investors Alert: Participants in RCI Hospitality Class Action Robbins LLP reminds stockholders that a crucial class action has been initiated for individuals and entities that acquired RCI Hospitality Holdings, Inc. (NASDAQ: RICK) securities within the specified timeframe. The complaint addresses serious allegations that RCI has been involved in improper activities,...

Continue Reading
Exploring the Future of the VSAT Market and Its Growth Potential

Updated Category News Views 312

Understanding the VSAT Market Dynamics The global Very Small Aperture Terminal (VSAT) market is experiencing remarkable growth, valued at approximately US$ 8.9 billion recently. This sector is projected to evolve significantly, aiming for a projected value of around US$ 22.0 billion by the end of the forecast period, reflecting a strong compound annual growth rate (CAGR)...

Continue Reading
PAAMC HK Joins HKEX Fund Platform to Enhance Efficiency

Updated Category News Views 173

PAAMC HK's Participation in the HKEX Fund Platform Ping An of China Asset Management (PAAMC HK) is excited to announce its participation in the Hong Kong Exchanges and Clearing Limited's (HKEX) Integrated Fund Platform (IFP). As one of the initial fund houses to join, PAAMC HK supports the launch of this innovative platform, specifically its new Order Routing Service,...

Continue Reading
Discover the Google Pixel 10 Series with Exceptional Verizon Deals

Updated Category News Views 195

Introducing the Google Pixel 10 Series on Verizon Experience the Pixel 10 series on America’s Largest Network with the best 5G service and a price lock for three years! [Highlights] Free Pixel 10 Pro: New and existing customers can receive a Pixel 10 Pro with a trade-in of any Google, Apple, Motorola, or Samsung smartphone in any condition, specifically under the...

Continue Reading